Cargando…

Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia

BACKGROUND: Immunotherapies such as adoptive immune cell infusion and immune-modulating agents are widely used for cancer treatment, and the concomitant symptoms, including cytokine release syndrome (CRS) or immune-related adverse events (irAEs), are frequently reported. However, clinical manifestat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Bo, Zou, Xiaoyan, Ning, Xin, Liu, Tieqiang, Li, Bingxia, Lei, Yaqing, Qiao, Jianhui, Hu, Kaixun, Lei, Yangyang, Liu, Zhiqing, Yao, Bo, Ai, Huisheng, Wang, Yi, Yu, Changlin, Guo, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150921/ https://www.ncbi.nlm.nih.gov/pubmed/37027433 http://dx.doi.org/10.1097/CM9.0000000000002611

Ejemplares similares

Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia
por: Cai, Bo, et al.
Publicado: (2022)

Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL
por: Yu, Changlin, et al.
Publicado: (2020)

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia
por: Cai, Bo, et al.
Publicado: (2016)

Severe acute radiation syndrome: treatment of a lethally (60)Co-source irradiated accident victim in China with HLA-mismatched peripheral blood stem cell transplantation and mesenchymal stem cells
por: Guo, Mei, et al.
Publicado: (2014)

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
por: Reagan, J L, et al.
Publicado: (2015)

Subset-specific Retention of Donor Myeloid Cells After Major Histocompatibility Complex-matched and Mismatched Liver Transplantation
por: Dart, Sarah J., et al.
Publicado: (2023)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
por: Stadler, Michael, et al.
Publicado: (2022)

Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
por: Zhao, Peng, et al.
Publicado: (2021)

Donor-Recipient Size Mismatch in Paediatric Renal Transplantation
por: Donati-Bourne, J., et al.
Publicado: (2014)

Donor and Recipient Age-Mismatches: The Potential of Transferring Senescence
por: Iske, Jasper, et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2021)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
por: Liberatore, Carmine, et al.
Publicado: (2022)

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis
por: Tie, Ruxiu, et al.
Publicado: (2017)

Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report
por: Zhang, Cheng, et al.
Publicado: (2019)

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
por: Zhang, Yu, et al.
Publicado: (2023)

Effect of recipient-donor sex and weight mismatch on graft survival after deceased donor renal transplantation
por: Tillmann, Frank-Peter, et al.
Publicado: (2019)

A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
por: Wei, Yan, et al.
Publicado: (2023)

Donor Cell Myeloid Sarcoma
por: Walshauser, Mark A., et al.
Publicado: (2014)

Understanding anti-leukemia responses to donor lymphocyte infusion
por: Bachireddy, Pavan, et al.
Publicado: (2014)

Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
por: Rujkijyanont, P, et al.
Publicado: (2013)

Pretransplant Infusion of Donor B Cells Enhances Donor-Specific Skin Allograft Survival
por: Gao, Julia, et al.
Publicado: (2013)

A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)
por: Oberbauer, Rainer, et al.
Publicado: (2021)

HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients
por: Xu, Ruonan, et al.
Publicado: (2021)

Post‐prophylaxis Toxoplasma chorioretinitis following donor–recipient mismatched liver transplantation
por: Webb, G.J., et al.
Publicado: (2016)

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants
por: Müller-Deile, Janina, et al.
Publicado: (2017)

Influence of donor–recipient sex mismatch on long-term survival of pancreatic grafts
por: Li, Zhiwei, et al.
Publicado: (2016)

Extreme size mismatch: bronchus compression by an oversized donor heart in small children
por: Fu, Hsun-Yi, et al.
Publicado: (2022)

Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts
por: Huang, Chuwen, et al.
Publicado: (2021)

Role of mismatch repair in aging
por: Wen, Jie, et al.
Publicado: (2021)

Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
por: Sanna, Marco, et al.
Publicado: (2013)

Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
por: Rettig, Andrés R., et al.
Publicado: (2021)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Outcome of donor and recipient sex match versus mismatch in stem cell transplant procedure
por: Ali, Natasha, et al.
Publicado: (2019)

Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms
por: Jethwani, Priyanka, et al.
Publicado: (2022)

The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022)

Ensuring pulmonary artery patency in donor-recipient size mismatch: A collaborative challenge
por: Kumar, Nicolas, et al.
Publicado: (2021)

Risk Due to ABO Incompatibility and Donor-Recipient Weight Mismatch in Living Donor Kidney Transplantation: A National Cohort Study
por: Lee, Jun Young, et al.
Publicado: (2021)

Alternative Donor Transplantation for Acute Myeloid Leukemia
por: Bejanyan, Nelli, et al.
Publicado: (2015)

Rapid Recovery from Chronic PRCA by MSC Infusion in Patient after Major ABO-Mismatched alloSCT
por: Sergeevicheva, Vera, et al.
Publicado: (2012)

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
por: Li, Xuefeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5l7873qfjmj4e7clungrs3r8c